Literature DB >> 14594332

Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio.

Michael G Aman1, Kristen S L Lam, Angie Collier-Crespin.   

Abstract

To date, there have been few surveys of psychotropic and antiepileptic drug (AED) prevalence in individuals with autism-spectrum conditions. We surveyed 747 families in the Autism Society of Ohio regarding the use of psychotropic drugs, AEDs, and over-the-counter (OTC) preparations for autism. In all, 417 families (55.8%) replied. A total of 45.6% were taking some form of psychotropic agent (including St. John's wort and melatonin), whereas 11.5% were taking AEDs, and 10.3% took OTC autism preparations. The most common psychotropic agents included antidepressants (21.6%), antipsychotics (14.9%), antihypertensives (12.5%), and stimulants (11.3%). Some 51.6% were prescribed psychotropic drugs or AEDs, and 55.4% took psychotropic drugs, AEDs, or autism supplements. Demographic variables frequently found to be associated with medication use included greater age, more severe autism, more severe intellectual handicap, and housing outside the family home. Whereas there is empirical support for the use of some of these psychotropic agents in autism, others are being prescribed with minimal research support. OTC autism preparations were used in substantial numbers of individuals, despite limited research support and the possibility of toxic effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594332     DOI: 10.1023/a:1025883612879

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  12 in total

1.  Expert Consensus Guideline Series: Treatment of psychiatric and behavioral problems in mental retardation.

Authors: 
Journal:  Am J Ment Retard       Date:  2000-05

Review 2.  Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders.

Authors:  M G Aman; K S Langworthy
Journal:  J Autism Dev Disord       Date:  2000-10

3.  Coding ordinal independent variables in multiple regression analyses.

Authors:  S D Walter; A R Feinstein; C K Wells
Journal:  Am J Epidemiol       Date:  1987-02       Impact factor: 4.897

4.  Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.

Authors:  M G Aman; G Sarphare; W H Burrow
Journal:  Am J Ment Retard       Date:  1995-03

5.  Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.

Authors:  M G Aman; M E Van Bourgondien; P L Wolford; G Sarphare
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-12       Impact factor: 8.829

Review 6.  Controversies in the treatment of autistic children: vitamin and drug therapy.

Authors:  B Rimland
Journal:  J Child Neurol       Date:  1988       Impact factor: 1.987

7.  Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.

Authors:  A Martin; L Scahill; A Klin; F R Volkmar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-07       Impact factor: 8.829

Review 8.  Psychopharmacoepidemiology of mental retardation: 1966 to 1995.

Authors:  N N Singh; C R Ellis; H Wechsler
Journal:  J Child Adolesc Psychopharmacol       Date:  1997       Impact factor: 2.576

9.  Appropriate and inappropriate use of psychotherapeutic medications for institutionalized mentally retarded persons.

Authors:  W J Bates; D J Smeltzer; S M Arnoczky
Journal:  Am J Ment Defic       Date:  1986-01

10.  Risperidone in children with autism and serious behavioral problems.

Authors:  James T McCracken; James McGough; Bhavik Shah; Pegeen Cronin; Daniel Hong; Michael G Aman; L Eugene Arnold; Ronald Lindsay; Patricia Nash; Jill Hollway; Christopher J McDougle; David Posey; Naomi Swiezy; Arlene Kohn; Lawrence Scahill; Andres Martin; Kathleen Koenig; Fred Volkmar; Deirdre Carroll; Allison Lancor; Elaine Tierney; Jaswinder Ghuman; Nilda M Gonzalez; Marco Grados; Benedetto Vitiello; Louise Ritz; Mark Davies; James Robinson; Don McMahon
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  30 in total

1.  Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice.

Authors:  Cheryl A Frye; Danielle C Llaneza
Journal:  Physiol Behav       Date:  2010-03-16

2.  Employment and post-secondary educational activities for young adults with autism spectrum disorders during the transition to adulthood.

Authors:  Julie Lounds Taylor; Marsha Mailick Seltzer
Journal:  J Autism Dev Disord       Date:  2011-05

3.  Prevalence and Treatment Patterns of Autism Spectrum Disorder in the United States, 2016.

Authors:  Guifeng Xu; Lane Strathearn; Buyun Liu; Matthew O'Brien; Todd G Kopelman; Jing Zhu; Linda G Snetselaar; Wei Bao
Journal:  JAMA Pediatr       Date:  2019-02-01       Impact factor: 16.193

Review 4.  Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice.

Authors:  Matthew Siegel; Amy A Beaulieu
Journal:  J Autism Dev Disord       Date:  2012-08

5.  Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder.

Authors:  Paul T Shattuck; Marsha Mailick Seltzer; Jan S Greenberg; Gael I Orsmond; Daniel Bolt; Sheilah Kring; Julie Lounds; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2006-12-05

6.  Medical expenditures for children with an autism spectrum disorder in a privately insured population.

Authors:  Tom T Shimabukuro; Scott D Grosse; Catherine Rice
Journal:  J Autism Dev Disord       Date:  2007-08-10

7.  Psychotropic drug treatments for people with autism and other developmental disorders: a primer for practicing behavior analysts.

Authors:  Marc Weeden; Kristal Ehrhardt; Alan Poling
Journal:  Behav Anal Pract       Date:  2010

8.  Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999.

Authors:  David S Mandell; Jun Cao; Richard Ittenbach; Jennifer Pinto-Martin
Journal:  J Autism Dev Disord       Date:  2006-05

9.  Engagement in vocational activities promotes behavioral development for adults with autism spectrum disorders.

Authors:  Julie Lounds Taylor; Leann E Smith; Marsha R Mailick
Journal:  J Autism Dev Disord       Date:  2014-06

10.  Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.

Authors:  Michael G Aman; Alexander A Vinks; Bart Remmerie; Erik Mannaert; Yaser Ramadan; Jessica Masty; Ronald L Lindsay; Krista Malone
Journal:  Clin Ther       Date:  2007-07       Impact factor: 3.393

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.